MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 6795-6803
Publisher
Informa UK Limited
Online
2020-07-13
DOI
10.2147/ott.s260509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MCTS1 Directly Binds to TWF1 and Synergistically Modulate Cyclin D1 and C-Myc Translation in Luminal A/B Breast Cancer Cells
- (2020) Chao Tian et al. OncoTargets and Therapy
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- The altered transcriptome and DNA methylation profiles of docetaxel resistance in breast cancer PDX models
- (2019) Jorge Gómez-Miragaya et al. MOLECULAR CANCER RESEARCH
- Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer
- (2019) Bruno R. B. Pires et al. Oxidative Medicine and Cellular Longevity
- Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo
- (2019) Zhe Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Baicalin Inhibits Cell Viability, Migration and Invasion in Breast Cancer by Regulating miR-338-3p and MORC4
- (2019) Xin Duan et al. OncoTargets and Therapy
- Aberrant high expression level of MORC2 is a common character in multiple cancers
- (2018) Qian-shan Ding et al. HUMAN PATHOLOGY
- MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p
- (2018) Zi’ang Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CLDN6 promotes chemoresistance through GSTP1 in human breast cancer
- (2017) Minlan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
- (2017) Angela DeMichele et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis
- (2016) Guoju Hong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo
- (2016) Lan Wang et al. Frontiers of Medicine
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth
- (2015) Cecilia J. Proietti et al. MOLECULAR ENDOCRINOLOGY
- Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis
- (2015) L Venturutti et al. ONCOGENE
- Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
- (2015) J Niu et al. ONCOGENE
- Broad targeting of resistance to apoptosis in cancer
- (2015) Ramzi M. Mohammad et al. SEMINARS IN CANCER BIOLOGY
- Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism
- (2014) Roser Corominas et al. Nature Communications
- Luminal breast cancer: from biology to treatment
- (2013) Michail Ignatiadis et al. Nature Reviews Clinical Oncology
- The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
- (2010) David Warde-Farley et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started